메뉴 건너뛰기




Volumn 130, Issue 4, 2014, Pages 298-307

Fibroblast growth factor-23 and incident atrial fibrillation: The multi-ethnic study of atherosclerosis (MESA) and the cardiovascular health study (CHS)

Author keywords

atrial fibrillation; chronic; fibroblast growth factors; minerals; renal insufficiency

Indexed keywords

25 HYDROXYVITAMIN D; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; FIBROBLAST GROWTH FACTOR 23; PARATHYROID HORMONE; PHOSPHATE;

EID: 84904599025     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.113.005499     Document Type: Article
Times cited : (131)

References (53)
  • 2
    • 0035832261 scopus 로고    scopus 로고
    • Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The anticoagulation and risk factors in atrial fibrillation (ATRIA) study
    • Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285:2370-2375.
    • (2001) JAMA , vol.285 , pp. 2370-2375
    • Go, A.S.1    Hylek, E.M.2    Phillips, K.A.3    Chang, Y.4    Henault, L.E.5    Selby, J.V.6    Singer, D.E.7
  • 4
    • 79959736442 scopus 로고    scopus 로고
    • Estimation of total incremental health care costs in patients with atrial fibrillation in the United States
    • Kim MH, Johnston SS, Chu BC, Dalal MR, Schulman KL. Estimation of total incremental health care costs in patients with atrial fibrillation in the United States. Circ Cardiovasc Qual Outcomes. 2011;4:313-320.
    • (2011) Circ Cardiovasc Qual Outcomes , vol.4 , pp. 313-320
    • Kim, M.H.1    Johnston, S.S.2    Chu, B.C.3    Dalal, M.R.4    Schulman, K.L.5
  • 5
    • 0034943511 scopus 로고    scopus 로고
    • Trends in hospital activity, morbidity and case fatality related to atrial fibrillation in Scotland, 1986-1996
    • Stewart S, MacIntyre K, MacLeod MM, Bailey AE, Capewell S, McMurray JJ. Trends in hospital activity, morbidity and case fatality related to atrial fibrillation in Scotland, 1986-1996. Eur Heart J. 2001;22:693-701.
    • (2001) Eur Heart J , vol.22 , pp. 693-701
    • Stewart, S.1    Macintyre, K.2    Macleod, M.M.3    Bailey, A.E.4    Capewell, S.5    McMurray, J.J.6
  • 6
    • 1342301530 scopus 로고    scopus 로고
    • Cost of an emerging epidemic: An economic analysis of atrial fibrillation in the UK
    • Stewart S, Murphy NF, Murphy N, Walker A, McGuire A, McMurray JJ. Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK. Heart. 2004;90:286-292.
    • (2004) Heart , vol.90 , pp. 286-292
    • Stewart, S.1    Murphy, N.F.2    Murphy, N.3    Walker, A.4    McGuire, A.5    McMurray, J.J.6
  • 7
    • 0043164965 scopus 로고    scopus 로고
    • Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: Implications for primary prevention
    • Wattigney WA, Mensah GA, Croft JB. Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention. Circulation. 2003;108:711-716.
    • (2003) Circulation , vol.108 , pp. 711-716
    • Wattigney, W.A.1    Mensah, G.A.2    Croft, J.B.3
  • 17
    • 77956159370 scopus 로고    scopus 로고
    • FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment
    • Seiler S, Reichart B, Roth D, Seibert E, Fliser D, Heine GH. FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment. Nephrol Dial Transplant. 2010;25:3983-3989.
    • (2010) Nephrol Dial Transplant , vol.25 , pp. 3983-3989
    • Seiler, S.1    Reichart, B.2    Roth, D.3    Seibert, E.4    Fliser, D.5    Heine, G.H.6
  • 18
    • 84868588143 scopus 로고    scopus 로고
    • Diastolic dysfunction and risk of atrial fibrillation: A mechanistic appraisal
    • Rosenberg MA, Manning WJ. Diastolic dysfunction and risk of atrial fibrillation: a mechanistic appraisal. Circulation. 2012;126:2353-2362.
    • (2012) Circulation , vol.126 , pp. 2353-2362
    • Rosenberg, M.A.1    Manning, W.J.2
  • 19
  • 22
    • 84902826865 scopus 로고    scopus 로고
    • Fibroblast growth factor-23 and cardiovascular disease in the general population: The multi-ethnic study of atherosclerosis
    • [published online ahead of print March 25, 2014]. doi: 10.1161/ CIRCHEARTFAILURE.113.000952 Accessed May 30, 2014
    • Kestenbaum B, Sachs MC, Hoofnagle AN, Siscovick DS, Ix JH, Robinson-Cohen C, Lima JA, Polak JF, Blondon M, Ruzinski J, Rock D, de Boer IH. Fibroblast growth factor-23 and cardiovascular disease in the general population: the Multi-Ethnic Study of Atherosclerosis [published online ahead of print March 25, 2014]. Circ Heart Fail. doi: 10.1161/ CIRCHEARTFAILURE.113.000952. http://circheartfailure.ahajournals. org/content/early/2014/03/25/ CIRCHEARTFAILURE.113.000952.long. Accessed May 30, 2014.
    • Circ Heart Fail
    • Kestenbaum, B.1    Sachs, M.C.2    Hoofnagle, A.N.3    Siscovick, D.S.4    Ix, J.H.5    Robinson-Cohen, C.6    Lima, J.A.7    Polak, J.F.8    Blondon, M.9    Ruzinski, J.10    Rock, D.11    De Boer, I.H.12
  • 28
    • 57449107274 scopus 로고    scopus 로고
    • The relationship of left ventricular mass and geometry to incident cardiovascular events: The MESA (multi-ethnic study of atherosclerosis) study
    • Bluemke DA, Kronmal RA, Lima JA, Liu K, Olson J, Burke GL, Folsom AR. The relationship of left ventricular mass and geometry to incident cardiovascular events: the MESA (Multi-Ethnic Study of Atherosclerosis) study. J Am Coll Cardiol. 2008;52:2148-2155.
    • (2008) J Am Coll Cardiol , vol.52 , pp. 2148-2155
    • Bluemke, D.A.1    Kronmal, R.A.2    Lima, J.A.3    Liu, K.4    Olson, J.5    Burke, G.L.6    Folsom, A.R.7
  • 29
    • 84874494238 scopus 로고    scopus 로고
    • A bias-corrected net reclassification improvement for clinical subgroups
    • Paynter NP, Cook NR. A bias-corrected net reclassification improvement for clinical subgroups. Med Decis Making. 2013;33:154-162.
    • (2013) Med Decis Making , vol.33 , pp. 154-162
    • Paynter, N.P.1    Cook, N.R.2
  • 30
    • 38849091997 scopus 로고    scopus 로고
    • Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond
    • Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27:157-172.
    • (2008) Stat Med , vol.27 , pp. 157-172
    • Pencina, M.J.1    D'Agostino Sr., R.B.2    D'Agostino Jr., R.B.3    Vasan, R.S.4
  • 34
    • 29244432482 scopus 로고    scopus 로고
    • Recommendations for chamber quantification: A report from the american society of echocardiography's guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the european association of echocardiography, a branch of the european society of cardiology
    • Chamber Quantification Writing Group, American Society of Echocardiography's Guidelines and Standards Committee, European Association of Echocardiography
    • Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ; Chamber Quantification Writing Group, American Society of Echocardiography's Guidelines and Standards Committee, European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc of Echocardiogr. 2005;18:1440-1463.
    • (2005) J Am Soc of Echocardiogr , vol.18 , pp. 1440-1463
    • Lang, R.M.1    Bierig, M.2    Devereux, R.B.3    Flachskampf, F.A.4    Foster, E.5    Pellikka, P.A.6    Picard, M.H.7    Roman, M.J.8    Seward, J.9    Shanewise, J.S.10    Solomon, S.D.11    Spencer, K.T.12    Sutton, M.S.13    Stewart, W.J.14
  • 37
    • 84863583292 scopus 로고    scopus 로고
    • FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages
    • European Uremic Toxin (EUTox) Work Group
    • Desjardins L, Liabeuf S, Renard C, Lenglet A, Lemke HD, Choukroun G, Drueke TB, Massy ZA; European Uremic Toxin (EUTox) Work Group. FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages. Osteoporos Int. 2012;23:2017-2025.
    • (2012) Osteoporos Int , vol.23 , pp. 2017-2025
    • Desjardins, L.1    Liabeuf, S.2    Renard, C.3    Lenglet, A.4    Lemke, H.D.5    Choukroun, G.6    Drueke, T.B.7    Massy, Z.A.8
  • 38
    • 67650892239 scopus 로고    scopus 로고
    • Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community
    • Mirza MA, Larsson A, Lind L, Larsson TE. Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community. Atherosclerosis. 2009;205:385-390.
    • (2009) Atherosclerosis , vol.205 , pp. 385-390
    • Mirza, M.A.1    Larsson, A.2    Lind, L.3    Larsson, T.E.4
  • 41
    • 78149412578 scopus 로고    scopus 로고
    • Fibroblast growth factor-23 is associated with C-reactive protein, serum phosphate and bone mineral density in chronic kidney disease
    • Manghat P, Fraser WD, Wierzbicki AS, Fogelman I, Goldsmith DJ, Hampson G. Fibroblast growth factor-23 is associated with C-reactive protein, serum phosphate and bone mineral density in chronic kidney disease. Osteoporos Int. 2010;21:1853-1861.
    • (2010) Osteoporos Int , vol.21 , pp. 1853-1861
    • Manghat, P.1    Fraser, W.D.2    Wierzbicki, A.S.3    Fogelman, I.4    Goldsmith, D.J.5    Hampson, G.6
  • 42
    • 30344466069 scopus 로고    scopus 로고
    • Is atrial fibrillation an inflammatory disorder?
    • Boos CJ, Anderson RA, Lip GY. Is atrial fibrillation an inflammatory disorder? Eur Heart J. 2006;27:136-149.
    • (2006) Eur Heart J , vol.27 , pp. 136-149
    • Boos, C.J.1    Anderson, R.A.2    Lip, G.Y.3
  • 43
    • 36048931675 scopus 로고    scopus 로고
    • Role of inflammation in initiation and perpetuation of atrial fibrillation: A systematic review of the published data
    • Issac TT, Dokainish H, Lakkis NM. Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data. J Am Coll Cardiol. 2007;50:2021-2028.
    • (2007) J Am Coll Cardiol , vol.50 , pp. 2021-2028
    • Issac, T.T.1    Dokainish, H.2    Lakkis, N.M.3
  • 47
    • 27744545673 scopus 로고    scopus 로고
    • Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease
    • Gutierrez O, Isakova T, Rhee E, Shah A, Holmes J, Collerone G, Jüppner H, Wolf M. Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J Am Soc Nephrol. 2005;16:2205-2215.
    • (2005) J Am Soc Nephrol , vol.16 , pp. 2205-2215
    • Gutierrez, O.1    Isakova, T.2    Rhee, E.3    Shah, A.4    Holmes, J.5    Collerone, G.6    Jüppner, H.7    Wolf, M.8
  • 48
    • 0344945402 scopus 로고    scopus 로고
    • Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers
    • Larsson T, Nisbeth U, Ljunggren O, Jüppner H, Jonsson KB. Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers. Kidney Int. 2003;64:2272-2279.
    • (2003) Kidney Int , vol.64 , pp. 2272-2279
    • Larsson, T.1    Nisbeth, U.2    Ljunggren, O.3    Jüppner, H.4    Jonsson, K.B.5
  • 49
    • 3242661165 scopus 로고    scopus 로고
    • Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency
    • Shigematsu T, Kazama JJ, Yamashita T, Fukumoto S, Hosoya T, Gejyo F, Fukagawa M. Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency. Am J Kidney Dis. 2004;44:250-256.
    • (2004) Am J Kidney Dis , vol.44 , pp. 250-256
    • Shigematsu, T.1    Kazama, J.J.2    Yamashita, T.3    Fukumoto, S.4    Hosoya, T.5    Gejyo, F.6    Fukagawa, M.7
  • 51
    • 84866398974 scopus 로고    scopus 로고
    • A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension
    • Pokushalov E, Romanov A, Corbucci G, Artyomenko S, Baranova V, Turov A, Shirokova N, Karaskov A, Mittal S, Steinberg JS. A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension. J Am Coll Cardiol. 2012;60:1163-1170.
    • (2012) J Am Coll Cardiol , vol.60 , pp. 1163-1170
    • Pokushalov, E.1    Romanov, A.2    Corbucci, G.3    Artyomenko, S.4    Baranova, V.5    Turov, A.6    Shirokova, N.7    Karaskov, A.8    Mittal, S.9    Steinberg, J.S.10
  • 53
    • 84873569337 scopus 로고    scopus 로고
    • Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease
    • Bansal N, Fan D, Hsu CY, Ordonez JD, Marcus GM, Go AS. Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease. Circulation. 2013;127:569-574.
    • (2013) Circulation , vol.127 , pp. 569-574
    • Bansal, N.1    Fan, D.2    Hsu, C.Y.3    Ordonez, J.D.4    Marcus, G.M.5    Go, A.S.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.